Sinensetin serves as an AMPK activator to inhibit RANKL-induced osteoclastogenesis via osteoclast cytoskeleton reorganization

Yijie Gao(Beijing University of Chinese Medicine), Fangming Song
Journal of Translational Medicine
July 18, 2025
Cited by 3


Related Papers